Survivin-specific T-cell reactivity correlates with tumor response and patient survival: A phase-II peptide vaccination trial in metastatic melanoma - Becker, Juergen C.; Andersen, Mads H.; Hofmeister-Mueller, Valeska; Wobser, Marion; Frey, Lidia; Sandig, Christiane; Walter, Steffen; Singh-Jasuja, Harpreet; Kämpgen, Eckhart; Opitz, Andreas; Zapatka, Marc; Broecker, Eva-B.; et al. (Cancer Immunology, Immunotherapy, 2012)
Keywords: Melanoma; Peptide vaccination; Survivin; T-cell reactivity; Therapy